Business Daily Comments on Lek Takeover Talks
Ljubljana, 18 September - Being state-run funds, the largest shareholders of Slovenia's drug maker Lek should be guided in their takeover talks with Switzerland's Novartis by the benefits Lek should expect from the takeover, a Slovenian financial daily observes on Wednesday, commenting on Tuesday's second round of talks between Novartis and the Pension Fund Management (KAD) and the Slovenian Reimbursement Fund (SOD).
The rest of this news item is available to subscribers.
The news item consists of 833 characters (without spaces) or 168 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.